Date | Time | Source | Announcement |
---|---|---|---|
31 Dec 2014 | 11:01 AM | Total Voting Rights | |
29 Dec 2014 | 02:48 PM | Director/PDMR Shareholding | |
29 Dec 2014 | 10:22 AM | Holding(s) in Company | |
24 Dec 2014 | 08:56 AM | Amended Director/PDMR Shareholding | |
24 Dec 2014 | 07:00 AM | Director/PDMR Shareholding | |
23 Dec 2014 | 04:40 PM | Second Price Monitoring Extn | |
23 Dec 2014 | 04:35 PM | Price Monitoring Extension | |
23 Dec 2014 | 07:57 AM | Admission to the Official List and to Trading |
Indivior is a pharmaceutical company that develops and sells treatments for addiction and other serious mental illnesses.
Founded in 1994 as a division of Reckitt Benckiser and demerged in 2014, Indivior is listed on the London Stock Exchange and the NASDAQ Global Select Market.
Indivior share price is listed in London under the ticker INDV.